Article Information
PubMed
Published By
History
- Received March 21, 2013
- Revision received May 31, 2013
- Accepted June 23, 2013
- First published August 14, 2013.
- Version of record published August 14, 2013.
Copyright & Usage
Copyright © 2013 the authors 0270-6474/13/3313320-06$15.00/0
Author Information
Author contributions
Author contributions: M.M., P.T.N., and S.E. designed research; M.M., J.F.S., I.P., and B.R.W. performed research; M.M., J.F.S., D.W.F., P.T.N., and S.E. analyzed data; S.E. wrote the paper.
Disclosures
- Received March 21, 2013.
- Revision received May 31, 2013.
- Accepted June 23, 2013.
This work was made possible by National Institutes of Health Grants P01-AGO30128 (SE), P30-AG028383 (D.W.F., P.T.N.), and P20-GM103436 (D.W.F.) and the University of Kentucky Bucks for Brains program (M.M.). The University of Kentucky has filed a provisional patent for CD33 inhibition in Alzheimer's disease that includes M.M., J.F.S., I.P., and S.E.
- Correspondence should be addressed to Dr. Steven Estus, Sanders-Brown Center on Aging, 800 South Limestone Street, Lexington, KY 40536. steve.estus{at}uky.edu
